CLC Number:
- R473.55
| [1]苏雷,高燕,陈航.环磷酰胺致多形红斑药疹1例[J].医学研究与教育,2009, 26(2):42. DOI:10.3969/j.issn.1674-490X.2009.02.046. [2]蔡亮,江珊,胡萍.环磷酰胺致多形红斑型药疹1例分析[J].中国误诊学杂志,2007,7(6):1331-1332.DOI:10.3969/j.issn.1009-6647.2007.06.165. [3]刘爱英,张瑞凤.环磷酰胺致药疹1例病例报道[J].中国社区医师(医学专业,2010,12(33):189.DOI:10.3969/j.issn.1007-614x.2010.33.205. [4]张秀英,王圣芳,张霞,等.静脉推注环磷酰胺引起过敏反应1例[J].齐鲁护理杂志,2005,11(2):187. DOI:10.3969/j.issn.1006-7256.2005.02.107. [5]Martin, M, Fornecker L M, Marcellin, L, et al. Acute and Fatal Cardiotoxicity Following High-dose Cyclophosphamide in a Patient Undergoing Autologous Stem Cell Transplantation for Systemic Sclerosis Despite Satisfactory Cardiopulmonary Screening[J]. Bone Marrow Transplant,2017,52(12):1674-1677.DOI:10.1038/bmt.2017.188. [6]Schjelderup P,El-Galaly T C, Frøkjær J B, et al. Acute Respiratory Failure during First Cyclophosphamide Infusion in a Patient with Systemic lupus Erythematosus[J]. 2014,73(10):939-941.DOI:10.1007/s00393-014-1381-4. [7]Unnikrishnan A, Glover S C, Norkina O, et al.Complete Resolution of Severe Ulcerative Colitis after Haploidentical Hematopoietic Stem Cell Transplantation followed by Post-transplant High-dose Cyclophosphamide[J]. Bone Marrow Transplant,2017,52(8):1204-1205.DOI:10.1038/bmt.2017.94. [8]岳燕,刘嵘,李君惠,等.异基因单倍型造血干细胞移植后应用环磷酰胺治疗幼年型粒单核细胞白血病6例报道[J].中国医刊,2018,53(2):192-197.DOI:10.3969/j.issn.1008-1070.2018.02.020. [9]刘桦,张佳丽.药物过敏反应的免疫学机制研究进展[J].中国现代应用药学,2006,23(4):284-286,297.DOI: 10.3969/j.issn.1007-7693.2006.04.008. [10]杨林,刘光辉.药物过敏发病机制及体内外检测[J].中华临床免疫和变态反应杂志,2012,6(2):152-157. DOI:10.3969/j.issn.1673-8705.2012.02.015. [11]孙健冰,杨秀玉,陈秀容.培门冬酶治疗恶性淋巴瘤30例护理[J].福建医药杂志,2016,38(2):158-159. |
| [1] | . [J]. Journal of Nursing, 2024, 31(22): 1-6. |
| [2] | . [J]. Journal of Nursing, 2024, 31(16): 6-11. |
| [3] | . [J]. Journal of Nursing, 2024, 31(16): 67-73. |
| [4] | LI Jing, HE Xin-yu, WANG Chun-xia, LI Dan-yang, ZHANG Mei-yun. Best evidence summary for exercise intervention in patients with multiple myeloma [J]. Journal of Nursing, 2024, 31(13): 62-66. |
| [5] | . [J]. Journal of Nursing, 2024, 31(2): 22-26. |
| [6] | ZHANG Yi, WANG Ai-hong, CHEN Jing. Reliability and Validity of Chinese version of Fatalism Scale in Patients with hematologic malignancies [J]. Journal of Nursing, 2023, 30(20): 54-57. |
| [7] | FANG Jia, XU Li-ling, LIU Chun-qin, LIU Xia, WANG Mei-xiang, LIU Qiong, HUANG Hai-ying, XIAO Xin-Hua, LIN Yan. Contemporaneous symptom networks in children with acute leukemia during chemotherapy: a network analysis [J]. Journal of Nursing, 2023, 30(16): 1-6. |
| [8] | XU Hui-juan, LIU Ying, YAO Jia-li, YAO Jing-jing, CHEN Min, QIU Tian-tian, XU Dan. Predictive power comparison of three different risk assessment models for symptomatic peripherally inserted central catheter related venous thromboembolism among patients with acute myeloblastic leukemia [J]. Journal of Nursing, 2023, 30(11): 59-64. |
| [9] | . [J]. Journal of Nursing, 2023, 30(5): 59-64. |
| [10] | . [J]. Journal of Nursing, 2023, 30(3): 63-67. |
| [11] | SHEN Xin-yi, LI Rong-rong, CHAN Yu-ying, ZHANG Guan-xun, YANG Qi, ZHANG Lin. Symptom Clusters and Sentinel Symptoms of Children with Acute Lymphoblastic Leukemia during Maintenance Chemotherapy [J]. Journal of Nursing, 2022, 29(15): 59-64. |
| [12] | RUAN Hai-tao, ZHANG Zi-yi, ZHOU Li, XU Li. Nursing of Leukemia Patients Undergoing Chimeric Antigen Receptor T-cell Therapy with Severe Neurotoxicity: A 2-case Study [J]. Journal of Nursing, 2022, 29(12): 67-69. |
| [13] | YAO jing-jing, LIU Ying, XU Hui-juan, SUN Si-min, CHEN Min, JIANG Xue-jie. Prevention and Management of Chemotherapy-induced Constipation in Patients with Acute Leukemia: A Evidence-based Nursing Practice Project [J]. Journal of Nursing, 2022, 29(8): 40-45. |
| [14] | LUO Yu-qin, LI Meng-xuan, CHENG Qiu, WANG Ting, ZHENG Jing-yu, FANG Jin-bo, GONG Yu-ping. Case-control Study on Risk Factors of Perianal Infection in Patients with Hematological Malignancy undergoing Chemotherapy [J]. Journal of Nursing, 2022, 29(7): 7-11. |
| [15] | . [J]. Journal of Nursing, 2021, 28(19): 52-58. |
|
||